Immunogenicity of biologic agents: a new concern for the practicing rheumatologist?
Haraoui
Boulos
B
University of Montreal Hospital Centre, Notre-Dame Hospital, Department of Medicine, University of Montreal, Montreal, Quebec, Canada. boulos.haraoui@ssss.gouv.qc.ca
Pelletier
Jean-Pierre
JP
Martel-Pelletier
Johanne
J
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology*; D000941:Antigens / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000276:immunology*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D000941:Antigens; D007155:Immunologic Factors
N Engl J Med. 2003 Feb 13;348(7):601-8
12584368
J Immunother. 2006 Jan-Feb;29(1):1-9
16365595
J Rheumatol. 2006 Jan;33(1):31-6
16395747